v3.22.2.2
SIGNIFICANT ACCOUNTING POLICIES AND OTHER RISKS AND UNCERTAINTIES (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Feb. 04, 2022
May 14, 2020
Sep. 30, 2022
Jun. 30, 2022
Sep. 30, 2022
Sep. 30, 2021
Mar. 31, 2022
Nov. 18, 2021
Nov. 04, 2021
Product Information [Line Items]                  
Net cash used in operating activities         $ 16,059 $ 8,898      
Accumulated losses     $ 146,541   146,541   $ 123,639    
Cash, cash equivalents, marketable securities and certain restricted cash     72,551   72,551   90,230    
Proceeds from issuance of common stock         1,031      
Restricted Cash     10,100   10,100   10,000    
Restricted cash and cash equivalents, current     7,400   7,400   7,400    
Marketable securities have maturities greater than 12 months     97   97        
Tax rebate     0 $ 182 $ 182 0      
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Two Third-party Vendors [Member]                  
Product Information [Line Items]                  
Concentration risk percentage         69.00%        
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Third Party Vendor One [Member]                  
Product Information [Line Items]                  
Concentration risk percentage         53.00%        
Accounts Payable [Member] | Supplier Concentration Risk [Member] | Third Party Vendor Two [Member]                  
Product Information [Line Items]                  
Concentration risk percentage         16.00%        
Contract Manufacturer [Member]                  
Product Information [Line Items]                  
Restricted Cash     2,600   $ 2,600   $ 2,600    
Stock Purchase Agreement [Member]                  
Product Information [Line Items]                  
Proceeds from issuance of common stock         0 $ 1,000      
At The Market Equity Offering [Member]                  
Product Information [Line Items]                  
Proceeds from issuance sale of equity $ 50,000       49,800        
Beyond Air and Beyond Cancer [Member]                  
Product Information [Line Items]                  
Cash, cash equivalents, marketable securities and certain restricted cash     65,000   65,000        
Beyond Air [Member]                  
Product Information [Line Items]                  
Net cash used in operating activities     7,123   12,635        
Cash, cash equivalents, marketable securities and certain restricted cash     $ 40,754   40,754        
Lincoln Park Capital Fund LLC [Member] | Stock Purchase Agreement [Member]                  
Product Information [Line Items]                  
Proceeds from issuance of common stock   $ 40,000              
Remaining available issuance of common stock         $ 18,100        
Beyond Cancer [Member]                  
Product Information [Line Items]                  
Equity method ownership percentage     80.00%   80.00%     20.00% 20.00%
Beyond Cancer [Member] | Noncontrolling Interest [Member]                  
Product Information [Line Items]                  
Equity method ownership percentage     20.00%   20.00%